Wall Street Zen Upgrades Arrowhead Pharmaceuticals (NASDAQ:ARWR) to Hold
Wall Street Zen upgraded shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) from a sell rating to a hold rating in a report released on Thursday. Several other equities research analysts have also commented on ARWR. Royal Bank of Canada restated an “outperform” rating and issued a $42.00 price target on shares of Arrowhead Pharmaceuticals […]
Wall Street Zen upgraded shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) from a sell rating to a hold rating in a report released on Thursday. Several other equities research analysts have also commented on ARWR. Royal Bank of Canada restated an “outperform” rating and issued a $42.00 price target on shares of Arrowhead Pharmaceuticals […]
